Lkb1-inactive Lung Adenocarcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-11-16
Clinical Trial Update: Metformin Plus/Minus Fasting Mimicking Diet to Target the Metabolic Vulnerabilities of LKB1-inactive Lung Adenocarcinoma [Phase 2]
Phase 2 trial investigating metformin with or without a fasting-mimicking diet for Advanced LKB1-inactive Lung Adenocarcinoma.